On the issue of diagnostic value of determining the level of receptors and their ligands in blood in non-small cell lung cancer
| العنوان: | On the issue of diagnostic value of determining the level of receptors and their ligands in blood in non-small cell lung cancer |
|---|---|
| المؤلفون: | D. I. Murashka, A. D. Tahanovich, M. M. Kauhanka, O. V. Gotko, V. I. Prokhorova |
| المصدر: | Russian Clinical Laboratory Diagnostics. 67:277-285 |
| بيانات النشر: | EKOlab, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Keratin-19, Medical Laboratory Technology, Lung Neoplasms, Antigens, Neoplasm, Carcinoma, Non-Small-Cell Lung, Interleukin-8, Biochemistry (medical), Humans, General Medicine, Ligands, Receptors, Interleukin-8B, Receptors, Interleukin-8A |
| الوصف: | Non-small cell lung cancer (NSCLC) occupies the first place in the structure of mortality due to oncological diseases. Late diagnosis worsens the effectiveness of its treatment. There are no informative biomarkers that allow us to judge the prevalence of the tumor process, especially in the early stages of NSCLC. To determine the level of CXCL5, CXCL8, CXCR1 and CXCR2 in the peripheral blood of patients with NSCLC to assess the possibility of their use in the diagnosis of the disease. The material was the blood of 218 patients with NSCLC, 19 patients with lung hamartoma and 42 healthy people. The concentration of CXCL5, CXCL8, and SCC in blood serum was determined by enzyme immunoassay, the CYFRA 21-1 level was determined by immunochemiluminescence analysis. The proportion of leukocytes equipped with CXCR1 and CXCR2 receptors and the fluorescence intensity of receptor complexes with antibodies (MFI) in them were measured by flow cytometry. MFI CXCR1 in granulocytes and the proportion of lymphocytes supplied CXCR2, increased in the blood already at stage I of NSCLC and showed an even more significant increase in subsequent stages. The level of these indicators was correlatively related to the stages and characteristics of NSCLC. Measuring the level of MFI CXCR1 in the blood serum makes it possible to diagnose the early stages of NSCLC with a sensitivity of 87.4% (specificity - 73.8%). Determination of the proportion of lymphocytes equipped with CXCR2 demonstrates comparable diagnostic sensitivity (87.2%) and specificity of 66.7% in the detection of stages I-II of NSCLC. MFI CXCR1 in granulocytes can also be used to differentiate stages I and II of NSCLC (diagnostic sensitivity - 75,3%, specificity - 69,6%). The sensitivity of determining for this purpose the proportion of lymphocytes equipped with CXCR2 is 75.0% with a specificity of 71.7%. In 89.7% of patients with stages III-IV NSCLC, the MFI CXCR1 in granulocytes exceeds the threshold value of 47.8 (specificity - 74.8%). Diagnostic sensitivity of determining the proportion of lymphocytes for this purpose was 90.7%. |
| تدمد: | 2412-1320 0869-2084 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6b009df212ee16791afecc755b2292Test https://doi.org/10.51620/0869-2084-2022-67-5-277-285Test |
| رقم الانضمام: | edsair.doi.dedup.....de6b009df212ee16791afecc755b2292 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 24121320 08692084 |
|---|